More than 80% of patients* suffering from cancer develop cutaneous side effects linked to the different treatments.

*Charles C, et al. Impact of cutaneous toxicity associated with targeted therapies on quality of life. Results of a longitudinal exploratory study. Bulletin du Cancer. March 2013;100(3):213-22.